deltatrials
Completed PHASE3 INTERVENTIONAL 2-arm NCT00331097

ELDA: Elderly Breast Cancer - Docetaxel in Adjuvant Treatment

Adjuvant Chemotherapy in Elderly Patients With Breast Cancer: Weekly Docetaxel vs. CMF

Sponsor: National Cancer Institute, Naples

Conditions Breast Cancer
Interventions 5-fluorouracil cyclophosphamide docetaxel methotrexate
Updated 7 times since 2017 Last updated: Mar 27, 2017 Started: Jul 31, 2003 Primary completion: May 31, 2014 Completion: Nov 30, 2014
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00331097, this PHASE3 trial focuses on Breast Cancer and remains completed. Sponsored by National Cancer Institute, Naples, it has been updated 7 times since 2003, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Apr 2017 · 3 months · monthly snapshotActive Not Recruiting~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshotCompleted~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

7 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE3

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

▶ Show 2 earlier versions

  1. Apr 2017 — Jun 2018 [monthly]

    Completed PHASE3

    Status: Active Not Recruiting → Completed

  2. Jan 2017 — Apr 2017 [monthly]

    Active Not Recruiting PHASE3

    First recorded

Jul 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • National Cancer Institute, Naples
Data source: National Cancer Institute, Naples

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations